Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022

Visit https://www.peervoice.com/YWF860 to view the entire programme with slides. After completing “Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022”, participants will be able to: Describe key safety and efficacy data for targeted and immunotherapies in molecular biomarker-positive non-small-cell lung cancer (NSCLC); Determine the impact and clinical implications of new evidence on the current treatment landscape in NSCLC; and Apply new data to improve the care and outcomes of patients with NSCLC.